Globus Medical (GMED) Operating Leases (2022 - 2026)

Globus Medical (GMED) has reported Operating Leases for 5 consecutive years, with $111.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases rose 3.03% year-over-year to $111.2 million; the trailing twelve-month figure through Jun 2026 stood at $111.2 million (up 3.03% YoY), and the FY2025 full-year result was $103.9 million, up 24.32% from the prior year.
• Operating Leases declined to $111.2 million in Q2 2026 per GMED's latest filing, from $115.2 million in the prior quarter.
• Across five years, Operating Leases topped out at $115.2 million in Q1 2026 and bottomed at $3.5 million in Q4 2022.
• Historically, Operating Leases has averaged $89.8 million across 5 years, with a median of $91.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Operating Leases surged 2519.77% in 2023, then fell 13.56% in 2024.
• Over 5 years, Operating Leases stood at $3.5 million in 2022, then soared by 2519.77% to $91.0 million in 2023, then retreated by 8.18% to $83.6 million in 2024, then rose by 24.32% to $103.9 million in 2025, then gained by 7.0% to $111.2 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $111.2 million, $115.2 million, and $103.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.